Breast Cancer Profiling Project, Drug Sensitivity phase II: Fixed-cell GR measures of 33 breast cell lines and PDX lines to 16 small molecule perturbagens from library plate II. Dataset 1 of 2: Normalized growth rate inhibition values - Dataset (ID:20354)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration (uM) | Mean Normalized Growth Rate Inhibition Value | Increased Fraction Dead |
---|---|---|---|---|
MDA-MB-231 | Ribociclib | 10.0 | 0.1421 | 0.02459 |
MDA-MB-231 | Ribociclib | 10.0 | 0.2071 | 0.02401 |
MDA-MB-231 | Ribociclib | 10.0 | 0.2166 | 0.03003 |
MDA-MB-231 | LY3023414 | 0.001 | 0.7211 | 0.00401 |
MDA-MB-231 | LY3023414 | 0.001 | 0.7634 | 0.00547 |
MDA-MB-231 | LY3023414 | 0.001 | 0.8153 | -0.00244 |
MDA-MB-231 | LY3023414 | 0.003162278 | 0.5869 | -0.00312 |
MDA-MB-231 | LY3023414 | 0.003162278 | 0.5782 | 0.00050 |
MDA-MB-231 | LY3023414 | 0.003162278 | 0.5864 | 0.01000 |
MDA-MB-231 | LY3023414 | 0.01 | 0.5674 | -0.00077 |
MDA-MB-231 | LY3023414 | 0.01 | 0.5721 | -0.00278 |
MDA-MB-231 | LY3023414 | 0.01 | 0.6069 | -0.00056 |
MDA-MB-231 | LY3023414 | 0.031622777 | 0.2430 | 0.19726 |
MDA-MB-231 | LY3023414 | 0.031622777 | 0.5056 | -0.00321 |
MDA-MB-231 | LY3023414 | 0.031622777 | 0.4413 | 0.01115 |
MDA-MB-231 | LY3023414 | 0.1 | 0.3242 | 0.00065 |
MDA-MB-231 | LY3023414 | 0.1 | 0.3650 | -0.00362 |
MDA-MB-231 | LY3023414 | 0.1 | 0.3799 | 0.01169 |
MDA-MB-231 | LY3023414 | 0.316227766 | 0.3027 | 0.02478 |
MDA-MB-231 | LY3023414 | 0.316227766 | 0.3724 | 0.01040 |
MDA-MB-231 | LY3023414 | 0.316227766 | 0.3616 | 0.01049 |
MDA-MB-231 | LY3023414 | 1.0 | 0.2703 | 0.00649 |
MDA-MB-231 | LY3023414 | 1.0 | 0.2877 | -0.00099 |
MDA-MB-231 | LY3023414 | 1.0 | 0.2517 | -0.00292 |
MDA-MB-231 | LY3023414 | 3.16227766 | 0.2045 | 0.01236 |